What are the features of infliximab-induced liver injury?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18215258
Cited by: 0

Abstract

Infliximab-induced liver injury includes autoimmune-like features and can range from mild enzyme elevations to severe liver failure. Discontinuation of therapy generally leads to recovery, yet the variability in presentation urges careful monitoring.

Fields of Study & Subjects

Drug-Induced Hepatotoxicity and Protection Pharmacovigilance and Adverse Drug Reactions Immunotoxicology and immune responses

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
11 January 2026